Pacira Biosciences, Inc. · NASDAQ:PCRX
Slonin Jonathan sold 3,040 Pacira Biosciences, Inc. shares (Form 4)
Traded Aug 17, 2026 · Filed Aug 18, 2026
On Aug 17, 2026, Slonin Jonathan (Chief Medical Officer) sold 3,040 Pacira Biosciences, Inc. shares at US$23.23 for US$70,619 under a trading plan, leaving 216,384 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 3,040 shares
- Price
- US$23.23
- Value
- US$70,619
- Holding after
- 216,384 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Sale | 3,040 | US$23.23 | 216,384 | Direct |
Source
Related
- Pacira Biosciences, Inc.
- Slonin Jonathan
- Pacira Biosciences, Inc. shareholders
- Form 4 · Slonin Jonathan · Jun 5, 2026
- Schedule 13D/A · Doma Perpetual Capital Management LLC · Oct 13, 2026
- Form 4 · Riker Lauren · Oct 9, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Riker Lauren · Jun 12, 2026
- Form 4 · Hirawat Samit · Jun 12, 2026